Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration

References

• Stoltz RA, Conners MS, Gerritsen ME, Abraham NG, Laniado-Schwartzman M. Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal-derived eicosanoid. Am J Pathol 1996; 148:129-39; PMID:8546200
   PubMed Web of Science ®Google Scholar
• Scher CD, Stiles CD, Antoniades HN, Pledger WJ. Regulation of the mammalian fibroblast cell cycle by a platelet-derived growth factor. Prog Clin Biol Res 1979; 31:611-20; PMID:538019
   PubMedGoogle Scholar
• Suryadinata R, Sadowski M, Sarcevic B. Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates. Biosci Rep 2010; 30:243-55; PMID:20337599; http://dx.doi.org/10.1042/BSR20090171
   PubMed Web of Science ®Google Scholar
• Tam SW, Theodoras AM, Shay JW, Draetta GF, Pagano M. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene 1994; 9:2663-74; PMID:8058330
   PubMed Web of Science ®Google Scholar
• Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14:2077-86; PMID:8114739; http://dx.doi.org/10.1128/MCB.14.3.2077
   PubMed Web of Science ®Google Scholar
• Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992; 257:1689-94; PMID:1388288; http://dx.doi.org/10.1126/science.1388288
   PubMed Web of Science ®Google Scholar
• Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11:961-71; PMID:1312467
   PubMed Web of Science ®Google Scholar
• Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 1988; 54:17-26; PMID:3289755; http://dx.doi.org/10.1016/0092-8674(88)90175-4
   PubMed Web of Science ®Google Scholar
• Jessus C, Beach D. Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B. Cell 1992; 68:323-32; PMID:1310257; http://dx.doi.org/10.1016/0092-8674(92)90473-P
   PubMed Web of Science ®Google Scholar
• Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung YK. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246:1300-3; PMID:2588006; http://dx.doi.org/10.1126/science.2588006
   PubMed Web of Science ®Google Scholar
• Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991; 67:293-302; PMID:1655277; http://dx.doi.org/10.1016/0092-8674(91)90181-W
   PubMed Web of Science ®Google Scholar
• Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1992; 6:177-85; PMID:1531329; http://dx.doi.org/10.1101/gad.6.2.177
   PubMed Web of Science ®Google Scholar
• Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365:349-52; PMID:8377827; http://dx.doi.org/10.1038/365349a0
   PubMed Web of Science ®Google Scholar
• Lee C, Chang JH, Lee HS, Cho Y. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. Genes Dev 2002; 16:3199-212; PMID:12502741; http://dx.doi.org/10.1101/gad.1046102
   PubMed Web of Science ®Google Scholar
• Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391:597-601; PMID:9468139; http://dx.doi.org/10.1038/35404
   PubMed Web of Science ®Google Scholar
• Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998; 92:463-73; PMID:9491888; http://dx.doi.org/10.1016/S0092-8674(00)80940-X
   PubMed Web of Science ®Google Scholar
• Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998; 391:601-5; PMID:9468140; http://dx.doi.org/10.1038/35410
   PubMed Web of Science ®Google Scholar
• Hassig CA, Schreiber SL. Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol 1997; 1:300-8; PMID:9667866; http://dx.doi.org/10.1016/S1367-5931(97)80066-X
   PubMed Web of Science ®Google Scholar
• Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC, Tsai SC, Seto E, Zhang Y, Kuzmichev A, et al. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol 2001; 21:2918-32; PMID:11283269; http://dx.doi.org/10.1128/MCB.21.8.2918-2932.2001
   PubMed Web of Science ®Google Scholar
• Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG Jr., Seto E, Branton PE. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol Cell Biol 1999; 19:6632-41; PMID:10490602; http://dx.doi.org/10.1128/MCB.19.10.6632
   PubMed Web of Science ®Google Scholar
• Suryadinata R, Sadowski M, Steel R, Sarcevic B. Cyclin-dependent kinase-mediated phosphorylation of RBP1 and pRb promotes their dissociation to mediate release of the SAP30.mSin3.HDAC transcriptional repressor complex. J Biol Chem 2011; 286:5108-18; PMID:21148318; http://dx.doi.org/10.1074/jbc.M110.198473
   PubMed Web of Science ®Google Scholar
• Dahiya A, Gavin MR, Luo RX, Dean DC. Role of the LXCXE binding site in Rb function. Mol Cell Biol 2000; 20:6799-805; PMID:10958676; http://dx.doi.org/10.1128/MCB.20.18.6799-6805.2000
   PubMed Web of Science ®Google Scholar
• Veitia RA, Ottolenghi C, Bissery MC, Fellous A. A novel human gene, encoding a potential membrane protein conserved from yeast to man, is strongly expressed in testis and cancer cell lines. Cytogenet Cell Genet 1999; 85:217-20; PMID:10449901; http://dx.doi.org/10.1159/000015296
   PubMedGoogle Scholar
• Ng HH, Bird A. Histone deacetylases: silencers for hire. Trends Biochem Sci 2000; 25:121-6; PMID:10694882; http://dx.doi.org/10.1016/S0968-0004(00)01551-6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997; 89:357-64; PMID:9150135; http://dx.doi.org/10.1016/S0092-8674(00)80216-0
   PubMed Web of Science ®Google Scholar
• Fleischer TC, Yun UJ, Ayer DE. Identification and characterization of three new components of the mSin3A corepressor complex. Mol Cell Biol 2003; 23:3456-67; PMID:12724404; http://dx.doi.org/10.1128/MCB.23.10.3456-3467.2003
   PubMed Web of Science ®Google Scholar
• Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H, Trouche D. RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J Biol Chem 2000; 275:9797-804; PMID:10734134; http://dx.doi.org/10.1074/jbc.275.13.9797
   PubMed Web of Science ®Google Scholar
• Qian YW, Lee EY. Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast. J Biol Chem 1995; 270:25507-13; PMID:7503932; http://dx.doi.org/10.1074/jbc.270.43.25507
   PubMed Web of Science ®Google Scholar
• Chen PL, Scully P, Shew JY, Wang JY, Lee WH. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58:1193-8; PMID:2673546; http://dx.doi.org/10.1016/0092-8674(89)90517-5
   PubMed Web of Science ®Google Scholar
• Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58:1097-105; PMID:2673543; http://dx.doi.org/10.1016/0092-8674(89)90508-4
   PubMed Web of Science ®Google Scholar
• Lundberg AS, Weinberg RA. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 1998; 18:753-61; PMID:9447971; http://dx.doi.org/10.1128/MCB.18.2.753
   PubMed Web of Science ®Google Scholar
• Zarkowska T, Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem 1997; 272:12738-46; PMID:9139732; http://dx.doi.org/10.1074/jbc.272.19.12738
   PubMed Web of Science ®Google Scholar
• Burke JR, Deshong AJ, Pelton JG, Rubin SM. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 2010; 285:16286-93; PMID:20223825; http://dx.doi.org/10.1074/jbc.M110.108167
   PubMed Web of Science ®Google Scholar
• Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 1999; 98:859-69; PMID:10499802; http://dx.doi.org/10.1016/S0092-8674(00)81519-6
   PubMed Web of Science ®Google Scholar
• Takaki T, Fukasawa K, Suzuki-Takahashi I, Hirai H. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. Biochem Biophys Res Commun 2004; 316:252-5; PMID:15003538; http://dx.doi.org/10.1016/j.bbrc.2004.02.044
   PubMed Web of Science ®Google Scholar
• Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 2004; 279:1562-9; PMID:14581478; http://dx.doi.org/10.1074/jbc.M307969200
   PubMed Web of Science ®Google Scholar
• Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res 2000; 60:2764-9; PMID:10850410
   PubMed Web of Science ®Google Scholar
• Roesley SNA, Suryadinata R, Sarcevic B. Metastasis suppressors and their roles in cancer. Cancer Forum 2014:90
   Google Scholar
• Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR, Shevde LA. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Molecular cancer 2007; 6:6; PMID:17227585; http://dx.doi.org/10.1186/1476-4598-6-6
   PubMed Web of Science ®Google Scholar
• Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Res 2005; 65:3586-95; PMID:15867352; http://dx.doi.org/10.1158/0008-5472.CAN-04-3139
   PubMed Web of Science ®Google Scholar
• Champine PJ, Michaelson J, Weimer BC, Welch DR, DeWald DB. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clin Exp Metast 2007; 24:551-65; PMID:17896182; http://dx.doi.org/10.1007/s10585-007-9092-8
   PubMed Web of Science ®Google Scholar
• Vaidya KS, Harihar S, Phadke PA, Stafford LJ, Hurst DR, Hicks DG, Casey G, DeWald DB, Welch DR. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J Biol Chem 2008; 283:28354-60; PMID:18664570; http://dx.doi.org/10.1074/jbc.M710068200
   PubMed Web of Science ®Google Scholar
• Weber C, Schreiber TB, Daub H. Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells. J Proteomics 2012; 75:1343-56; PMID:22115753; http://dx.doi.org/10.1016/j.jprot.2011.11.004
   PubMed Web of Science ®Google Scholar
• Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, Bailey DJ, Swaney DL, Tervo MA, Bolin JM, Ruotti V, et al. Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 2011; 8:821-7; PMID:21983960; http://dx.doi.org/10.1038/nmeth.1699
   PubMed Web of Science ®Google Scholar
• Rigbolt KT, Prokhorova TA, Akimov V, Henningsen J, Johansen PT, Kratchmarova I, Kassem M, Mann M, Olsen JV, Blagoev B. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 2011; 4:rs3; PMID:21406692; http://dx.doi.org/10.1126/scisignal.2001570
   PubMed Web of Science ®Google Scholar
• Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010; 3:ra3; PMID:20068231; http://dx.doi.org/10.1126/scisignal.2000475
   PubMed Web of Science ®Google Scholar
• Sharma K, D'Souza RC, Tyanova S, Schaab C, Wisniewski JR, Cox J, Mann M. Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling. Cell Rep 2014; 8:1583-94; PMID:25159151; http://dx.doi.org/10.1016/j.celrep.2014.07.036
   PubMed Web of Science ®Google Scholar
• Shiromizu T, Adachi J, Watanabe S, Murakami T, Kuga T, Muraoka S, Tomonaga T. Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res 2013; 12:2414-21; PMID:23312004; http://dx.doi.org/10.1021/pr300825v
   PubMed Web of Science ®Google Scholar
• Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics 2014; 96:253-62; PMID:24275569; http://dx.doi.org/10.1016/j.jprot.2013.11.014
   PubMed Web of Science ®Google Scholar
• Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol 1994; 4:973-82; PMID:7874496; http://dx.doi.org/10.1016/S0960-9822(00)00221-9
   PubMed Web of Science ®Google Scholar
• Songyang Z, Lu KP, Kwon YT, Tsai LH, Filhol O, Cochet C, Brickey DA, Soderling TR, Bartleson C, Graves DJ, et al. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol Cell Biol 1996; 16:6486-93; PMID:8887677; http://dx.doi.org/10.1128/MCB.16.11.6486
   PubMed Web of Science ®Google Scholar
• Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997; 243:527-36; PMID:9030781; http://dx.doi.org/10.1111/j.1432-1033.1997.t01-2-00527.x
   PubMedGoogle Scholar
• Vesely J, Havlicek L, Strnad M, Blow JJ, Donella-Deana A, Pinna L, Letham DS, Kato J, Detivaud L, Leclerc S, et al. Inhibition of cyclin-dependent kinases by purine analogues. Eur J Biochem 1994; 224:771-86; PMID:7925396; http://dx.doi.org/10.1111/j.1432-1033.1994.00771.x
   PubMedGoogle Scholar
• Hurst DR, Xie Y, Thomas JW, Liu J, Edmonds MD, Stewart MD, Welch DR. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. PLoS One 2013; 8:e55966; PMID:23390556; http://dx.doi.org/10.1371/journal.pone.0055966
   PubMed Web of Science ®Google Scholar
• Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009; 69:1279-83; PMID:19190326; http://dx.doi.org/10.1158/0008-5472.CAN-08-3559
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ye L, Tan Y, Sun P, Ji K, Jiang WG. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells. Anticancer Res 2014; 34:1417-26; PMID:24596389
   PubMed Web of Science ®Google Scholar
• Gurley LR, D'Anna JA, Barham SS, Deaven LL, Tobey RA. Histone phosphorylation and chromatin structure during mitosis in Chinese hamster cells. Eur J Biochem 1978; 84:1-15; PMID:206429; http://dx.doi.org/10.1111/j.1432-1033.1978.tb12135.x
   PubMedGoogle Scholar
• Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T, et al. Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 1999; 274:25543-9; PMID:10464286; http://dx.doi.org/10.1074/jbc.274.36.25543
   PubMed Web of Science ®Google Scholar
• Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998; 153:865-73; PMID:9736035; http://dx.doi.org/10.1016/S0002-9440(10)65628-3
   PubMed Web of Science ®Google Scholar
• Phillips KK, Welch DR, Miele ME, Lee JH, Wei LL, Weissman BE. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 1996; 56:1222-7; PMID:8640802
   PubMed Web of Science ®Google Scholar
• Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12:895-904; PMID:16892035; http://dx.doi.org/10.1038/nm1469
   PubMed Web of Science ®Google Scholar
• Leber MF, Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009; 34:881-95; PMID:19287945
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442-54; PMID:12189386; http://dx.doi.org/10.1038/nrc822
   PubMed Web of Science ®Google Scholar
• Bootsma D, Budke L, Vos O. Studies on synchronous division of tissue culture cells initiated by excess thymidine. Exp Cell Res 1964; 33:301-9; PMID:14109144; http://dx.doi.org/10.1016/S0014-4827(64)81035-1
   PubMed Web of Science ®Google Scholar
• Zhang S, Lin QD, Di W. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer 2006; 16:522-31; PMID:16681721; http://dx.doi.org/10.1111/j.1525-1438.2006.00547.x
   PubMed Web of Science ®Google Scholar
• Mei P, Bai J, Shi M, Liu Q, Li Z, Fan Y, Zheng J. BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells. PLoS One 2014; 9:e98544; PMID:24879377; http://dx.doi.org/10.1371/journal.pone.0098544
   PubMed Web of Science ®Google Scholar
• Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, et al. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metast 2000; 18:683-93; PMID:11827072; http://dx.doi.org/10.1023/A:1013124725690
   PubMed Web of Science ®Google Scholar
• Cicek M, Fukuyama R, Cicek MS, Sizemore S, Welch DR, Sizemore N, Casey G. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Clin Exp Metast 2009; 26:229-37; PMID:19165610; http://dx.doi.org/10.1007/s10585-009-9235-1
   PubMed Web of Science ®Google Scholar
• Liu Y, Smith PW, Jones DR. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 2006; 26:8683-96; PMID:17000776; http://dx.doi.org/10.1128/MCB.00940-06
   PubMed Web of Science ®Google Scholar
• Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 2009; 125:1778-85; PMID:19585508; http://dx.doi.org/10.1002/ijc.24616
   PubMed Web of Science ®Google Scholar
• Allard S, Kopish K. Luciferase reporter assays: Powerful, adaptable tools for cell biology research. Cell Notes 2008; 21:23-6
   Google Scholar
• Singhal H, Bautista DS, Tonkin KS, O'Malley FP, Tuck AB, Chambers AF, Harris JF. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clin Cancer Res 1997; 3:605-11; PMID:9815727
   PubMed Web of Science ®Google Scholar
• Oates AJ, Barraclough R, Rudland PS. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 1996; 13:97-104; PMID:8700559
   PubMed Web of Science ®Google Scholar
• Gavet O, Pines J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 2010; 18:533-43; PMID:20412769; http://dx.doi.org/10.1016/j.devcel.2010.02.013
   PubMed Web of Science ®Google Scholar
• Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Exp Cell Res 2002; 273:229-39; PMID:11822878; http://dx.doi.org/10.1006/excr.2001.5452
   PubMed Web of Science ®Google Scholar
• Seraj MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clin Exp Metast 2000; 18:519-25; PMID:11592309; http://dx.doi.org/10.1023/A:1011819621859
   PubMed Web of Science ®Google Scholar
• Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. Cancer Lett 2009; 276:196-203; PMID:19111386; http://dx.doi.org/10.1016/j.canlet.2008.11.024
   PubMed Web of Science ®Google Scholar
• Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, Donahue HJ. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 2001; 61:1765-7; PMID:11280719
   PubMed Web of Science ®Google Scholar
• Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Maelandsmo GM, Florenes VA. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. BMC Cancer 2012; 12:73; PMID:22356677; http://dx.doi.org/10.1186/1471-2407-12-73
   PubMed Web of Science ®Google Scholar
• Nagji AS, Liu Y, Stelow EB, Stukenborg GJ, Jones DR. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. J Pathol 2010; 221:229-37; PMID:20455258; http://dx.doi.org/10.1002/path.2707
   PubMed Web of Science ®Google Scholar
• Yang J, Shen Y, Liu B, Tong Y. Promoter methylation of BRMS1 correlates with smoking history and poor survival in non-small cell lung cancer patients. Lung Cancer 2011; 74:305-9; PMID:21726917; http://dx.doi.org/10.1016/j.lungcan.2011.03.002
   PubMed Web of Science ®Google Scholar
• Lombardi G, Di Cristofano C, Capodanno A, Iorio MC, Aretini P, Isola P, Tancredi M, Collecchi P, Naccarato AG, Porta RP, et al. High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis. Int J Cancer 2007; 120:1169-78; PMID:17163420; http://dx.doi.org/10.1002/ijc.22379
   PubMed Web of Science ®Google Scholar
• Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, et al. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clin Cancer Res 2006; 12:6702-8; PMID:17121889; http://dx.doi.org/10.1158/1078-0432.CCR-06-0635
   PubMed Web of Science ®Google Scholar
• Kim B, Nam HJ, Pyo KE, Jang MJ, Kim IS, Kim D, Boo K, Lee SH, Yoon JB, Baek SH, et al. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex. Biochem Biophys Res Commun 2011; 415:720-6; PMID:22085717; http://dx.doi.org/10.1016/j.bbrc.2011.10.154
   PubMed Web of Science ®Google Scholar
• Sarcevic B, Mawson A, Baker RT, Sutherland RL. Regulation of the ubiquitin-conjugating enzyme hHR6A by CDK-mediated phosphorylation. EMBO J 2002; 21:2009-18; PMID:11953320; http://dx.doi.org/10.1093/emboj/21.8.2009
   PubMed Web of Science ®Google Scholar
• Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11:211-9; PMID:7624138
   PubMed Web of Science ®Google Scholar
• Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, et al. Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 2003; 5:701-10; PMID:12855954; http://dx.doi.org/10.1038/ncb1020
   PubMed Web of Science ®Google Scholar
• Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol 2010; 20:453-60; PMID:20627573; http://dx.doi.org/10.1016/j.tcb.2010.05.002
   PubMed Web of Science ®Google Scholar
• Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat Cell Biol 2010; 12:1108-14; PMID:20935635; http://dx.doi.org/10.1038/ncb2116
   PubMed Web of Science ®Google Scholar
• Wei Y, Chen YH, Li LY, Lang J, Yeh SP, Shi B, Yang CC, Yang JY, Lin CY, Lai CC, et al. CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells. Nat Cell Biol 2011; 13:87-94; PMID:21131960; http://dx.doi.org/10.1038/ncb2139
   PubMed Web of Science ®Google Scholar
• Wu SC, Zhang Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 2011; 286:28511-9; PMID:21659531; http://dx.doi.org/10.1074/jbc.M111.240515
   PubMed Web of Science ®Google Scholar
• Tudhope SJ, Wang CC, Petrie JL, Potts L, Malcomson F, Kieswich J, Yaqoob MM, Arden C, Hampson LJ, Agius L. A novel mechanism for regulating hepatic glycogen synthesis involving serotonin and cyclin-dependent kinase-5. Diabetes 2012; 61:49-60; PMID:22106156; http://dx.doi.org/10.2337/db11-0870
   PubMed Web of Science ®Google Scholar
• Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y, Yang ES, Liu LP, Vaitheesvaran B, et al. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 2012; 122:2417-27; PMID:22684109; http://dx.doi.org/10.1172/JCI61462
   PubMed Web of Science ®Google Scholar
• Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 2001; 81:341-7; PMID:11371120; http://dx.doi.org/10.1006/gyno.2001.6196
   PubMed Web of Science ®Google Scholar
• Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57:353-61; PMID:8168995; http://dx.doi.org/10.1002/ijc.2910570311
   PubMed Web of Science ®Google Scholar
• Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997; 57:1634-7; PMID:9134998
   PubMed Web of Science ®Google Scholar
• Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-6; PMID:10201372; http://dx.doi.org/10.1038/18884
   PubMed Web of Science ®Google Scholar
• Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadea G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM. A novel function for Cyclin A2: control of cell invasion via RhoA signaling. J Cell Biol 2012; 196:147-62; PMID:22232705; http://dx.doi.org/10.1083/jcb.201102085
   PubMed Web of Science ®Google Scholar
• Liu F, Korc M. Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther 2012; 11:2138-48; PMID:22869556; http://dx.doi.org/10.1158/1535-7163.MCT-12-0562
   PubMed Web of Science ®Google Scholar
• Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 2012; 31:469-78; PMID:22729277; http://dx.doi.org/10.1007/s10555-012-9377-5
   PubMed Web of Science ®Google Scholar
• Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 2013; 19:1438-49; PMID:24202396; http://dx.doi.org/10.1038/nm.3336
   PubMed Web of Science ®Google Scholar
• Lehn S, Tobin NP, Berglund P, Nilsson K, Sims AH, Jirstrom K, Harkonen P, Lamb R, Landberg G. Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features. Am J Pathol 2010; 177:2886-97; PMID:20971731; http://dx.doi.org/10.2353/ajpath.2010.100303
   PubMed Web of Science ®Google Scholar
• Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G. Cyclin D1, Id1 and EMT in breast cancer. BMC Cancer 2011; 11:417; PMID:21955753; http://dx.doi.org/10.1186/1471-2407-11-417
   PubMed Web of Science ®Google Scholar
• Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, Berx G, Mellon JK, Tulchinsky E. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 2007; 18:4615-24; PMID:17855508; http://dx.doi.org/10.1091/mbc.E07-05-0406
   PubMed Web of Science ®Google Scholar
• Bae E, Sato M, Kim RJ, Kwak MK, Naka K, Gim J, Kadota M, Tang B, Flanders KC, Kim TA, et al. Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells. Cancer Res 2014; 74:6139-49; PMID:25205100; http://dx.doi.org/10.1158/0008-5472.CAN-14-0803
   PubMed Web of Science ®Google Scholar
• Rivera J, Megias D, Navas C, Bravo J. Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS One 2009; 4:e6433; PMID:19649328; http://dx.doi.org/10.1371/journal.pone.0006433
   PubMed Web of Science ®Google Scholar
• Barbaro V, Testa A, Di Iorio E, Mavilio F, Pellegrini G, De Luca M. C/EBPdelta regulates cell cycle and self-renewal of human limbal stem cells. J Cell Biol 2007; 177:1037-49; PMID:17562792; http://dx.doi.org/10.1083/jcb.200703003
   PubMed Web of Science ®Google Scholar
• Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72:8463-71; PMID:9765382
   PubMed Web of Science ®Google Scholar